New Delhi, June 26 (UNI) Seventy per cent of the treatment decisions are based on lab results. Yet, less than 30 per cent of the Indian population has ever got their blood test done.
'There is an alarming burden on the society from both communicable and non communicable diseases in India. Seventy per cent of the treatment decisions are based on lab results. Yet, less than 30 per cent of the Indian population has ever got their blood test done,' said a spokesperson for Transasia Bio-Medicals Ltd, country ’s leading In-vitro Diagnostic Company which recently organised a scientific seminar in East Delhi on the latest advancements in biochemistry and hematology for laboratories.
The major chunk of the 70 per cent population is in the smaller towns.
'At Transasia, we are committed to reaching out to the pathologists and clinicians in every nook and corner of the country, so that they are well equipped to cater to this population. TSS Ace is a unique platform that empowers the pathologists with the technological advances and encourages exchange of scientific updates, backed by expertise and experience.'
Titled Transasia Scientific Seminar (TSS) Ace, this pioneering academic initiative aims at encouraging the exchange of technical know-how among doctors.
The seminar focused on biochemistry and hematology - two of the most critical areas for in-vitro diagnostics.
The session on ‘Effective Use of Database Systems by doctors’ by Dr (Col) Arun Harith (Sr Consultant);
Head of Department-Biochemistry, Medanta Medicity, New Delhi, highlighted the growing need of
database for improving test outcomes.
Dr (Col) Jyoti Kotwal (Chairperson); Prof - Dept of Hematology, Sir Gangaram Hospital spoke on ‘Clinical Utility of Advanced Hematology Parameters.’ She emphasised on how the latest automation in hematology helps in enumeration of the different parameters such as IPF, Ret He, Immature Granulocytes, NRBC, etc. and how these parameters help in early diagnosis of diseases.
Transasia offers the entire range of semi and fully automated analysers and reagents in Biochemistry and Hematology. The latest in clinical chemistry is a fully automated, random access clinical chemistry analyzer, XL 1000 with a throughput of 1040 tests/ hour.
It offers a host of key features such as sample clot detection, permanent hard glass cuvettes and four channel direct ISE measurement, among others, making it an ideal choice for high volume labs.
The seminar was attended by pathologists, physicians and clinicians from reputed Government institutions including Delhi Cancer institute, IHBAS, Swami Dayanand Hospital, Rajiv Gandhi Super Specialty Hospital, Hegdewar Hospital, LBS Hospital and private institutes such as Max Healthcare, Kailash Healthcare Ltd, Yashoda Super Specialty Hospital, Dr Lal PathLabs, Metropolis and SRL Diagnostics.
UNI RSA SV0901